The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
I think those of us that take care of a lot of livers rely a lot less we we use our bread and and butter hepatic function panels which are not functions um necessarily but then we also use a lot of Imaging based tests because they're so much more sensitive um rather than these biomarkers that leave you with a lot of intermediate risk
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.